Veeco and Axcelis Lag Peers as AI Spurs Capex

Lead paragraph

Context

Shares of Veeco Instruments and Axcelis Technologies have underperformed larger semiconductor-equipment names even as AI-driven chip demand accelerates, according to MarketWatch (Mar 28, 2026). MarketWatch flagged the divergence between small- to mid-cap equipment suppliers and the sector leaders, noting Veeco and Axcelis have traded roughly 20–30% below the median performance of their larger peers in calendar 2026-to-date (MarketWatch, Mar 28, 2026). That underperformance stands in contrast to broader industry indicators: SEMI reported that global semiconductor equipment billings rose by 12% in 2025, highlighting ongoing capital expenditure growth across wafer fabs (SEMI, 2026). The juxtaposition—rising end-market demand and select stock weakness—raises questions about valuation, product-cycle exposure, and balance-sheet resilience for these two smaller equipment vendors.

The market is not monolithic: applied materials and LAM Research remain the proximate benchmarks for equipment-sector performance, and those names rallied strongly through late 2025 and into early 2026. For context, the PHLX Semiconductor Sector index (SOX) outperformed the broader market by approximately 8 percentage points in Q4 2025, driven by memory spending and logic fabs for AI processors (Source: market composite indices, Dec 2025). By contrast, Veeco and Axcelis are more narrowly exposed to specific subsegments—Veeco to deposition and metrology tools, Axcelis to ion-implantation—leaving them vulnerable to cyclical and product-specific timing differences. Institutional investors seeking exposure to AI-related capex therefore face a choice between the broad, benchmark-like exposure of large-cap equipment providers and the concentrated, higher-beta exposure of smaller specialists.

From a corporate standpoint, both companies have public financial histories that matter for analysis. Veeco's revenue mix historically includes LED and power-device related sales alongside advanced packaging and deposition for logic nodes; Axcelis is concentrated on ion implantation and implant-related services that are critical to certain logic and analog processes. Their revenue and margin sensitivity to specific fabs' technology roadmaps and node cycles means relative performance can diverge materially versus application-agnostic vendors. Investors should consider that divergence not only in absolute returns but in volatility, free cash flow generation, and the cadence of capital equipment orders.

Data Deep Dive

The headline data points driving headlines are threefold: stock performance, capex growth in the sector, and company-specific order books. MarketWatch (Mar 28, 2026) reported that Veeco and Axcelis lagged larger equipment peers through Q1 2026; headline estimates from market data vendors showed Veeco trading approximately 20–25% below the median peer return and Axcelis roughly 25–30% behind. On the demand side, SEMI's industry billings data for the full year 2025 indicated a 12% expansion versus 2024, driven by logic and foundry investments for AI chips (SEMI, 2026). These contrasting trajectories—robust equipment billings but selective equity underperformance—suggest market differentiation by perceived sustainable addressable market and pricing power.

Looking closer at order patterns, public disclosures and industry reporting indicate that Veeco's order book has been lumpy in recent quarters, with multi-quarter drums of demand for atomic layer deposition and epitaxy tools that are large but episodic. Axcelis' order flow is more correlated with logic/node transitions and the ramp of specialist fabs, which can create sharp order-book volatility as fabs time procurement. For example, a single large foundry ramp can represent several percentage points of annual revenue for a smaller capital-equipment vendor; by contrast, the same ramp for a diversified large-cap supplier dilutes materially. That concentration amplifies both upside and downside on reported quarterly numbers and complicates near-term forecasting.

Valuation metrics also show dispersion. Relative to Applied Materials and LAM Research, Veeco and Axcelis have historically traded at lower EV/EBITDA multiples, reflecting size, liquidity, and perceived cyclical risk. MarketWatch's March 28 note highlighted that the smaller names currently trade at discounts of 30–50% to larger equipment peers on trailing multiples (MarketWatch, Mar 28, 2026). For institutional investors this raises questions about whether the discount reflects structural risk (market share, intellectual property gaps), temporary sentiment, or a valuation opportunity if order visibility improves. Secondary indicators—inventory levels at chipmakers, lead times for key process tools, and fab capacity expansion announcements—are therefore crucial to triangulate the timing of any valuation re-rating.

Sector Implications

A shift in chipmakers' procurement strategies could either compress or widen the valuation gap. If foundries and IDMs accelerate orders for advanced logic and high-bandwidth memory to satisfy exponential AI model requirements, component-level suppliers that serve those nodes tend to experience strong sequential order flow. However, the benefits are uneven: large diversified equipment suppliers often capture the bulk of incremental spend due to breadth of tooling and aftermarket services, whereas niche suppliers can either gain outsized share or suffer from single-customer concentration risks. For Veeco and Axcelis, the path to sustained outperformance would likely require a combination of multi-quarter order momentum and visible aftermarket revenue.

Comparatively, large-cap players—Applied Materials, Lam Research, KLA—benefit from scale, service annuities, and a broader product set that reduces single-wafer exposure. Year-over-year (YoY) comparisons underline this: in prior equipment cycles, diversified suppliers have exhibited more stable margin progression and faster cash conversion than niche vendors. For example, during the 2017–2018 equipment cycle the leaders delivered quicker margin expansion and later earnings upgrades, whereas niche names saw higher amplitude swings. That historical pattern suggests institutional portfolios seeking benchmark-like exposure to AI-driven capex should remain weighted to larger equipment companies, while active allocations to smaller vendors require event-driven conviction.

Regulatory and geopolitical variables will also matter. Export controls, supply-chain localization and incentives in the U.S., Europe, and East Asia can reconfigure which suppliers are eligible for certain fabs' procurement lists. Since small suppliers may rely on a narrow customer base or on specific process nodes from a handful of foundries, any change in procurement policy or regional incentives can materially affect demand visibility. Those structural considerations are now standard inputs in advanced equipment procurement decisions, and they disproportionately affect the relative risk premia investors assign to Veeco and Axcelis vs. global peers.

Risk Assessment

The primary risks to a recovery in share prices for these names are straightforward: order volatility, competitive displacement and macro slowdown. Order volatility remains the most visible near-term hazard; a delayed fab ramp or a switch in process technology could ripple through quarterly results. For example, if a foundry switches to an alternative implant technology or a multi-patterning method that reduces demand for a specific class of tools, Axcelis and Veeco can see revenue downgrades more quickly than diversified peers. Investors should monitor announced fab schedules, management commentary on backlog, and customer footprints to assess this risk.

Competitive threats are also material. Large suppliers invest heavily in R&D and M&A to protect and extend their addressable markets; acquisition or product introductions by those leaders can crowd out smaller vendors. A single product win or loss with a leading foundry can change multi-year revenue trajectories for a niche equipment maker. Additionally, pricing pressure during peak demand periods—paradoxically—can compress unit margins if customers exert leverage in procurement, especially when capacity becomes constrained.

Macro downside—slowing AI investment growth or a broader capex retrenchment—remains an omnipresent tail risk. Even a partial slowdown in data center buildouts or AI training-cycle demand could reduce near-term spending on advanced nodes, with short-cycle repercussions for equipment orders. Given the cyclicality of semiconductor capital spending, historical downturns have shown equipment equities can fall materially faster than the broader semiconductor ecosystem, underscoring the importance of liquidity management and balance-sheet strength for smaller vendors.

Fazen Capital Perspective

Fazen Capital views the divergence between sector billings and stock-level performance as a classic market differentiation between breadth and concentration. The data—SEMI's reported 12% equipment billings growth for 2025 (SEMI, 2026) versus a roughly 20–30% equity underperformance for Veeco and Axcelis (MarketWatch, Mar 28, 2026)—suggests market participants are pricing in company-specific execution and concentration risk rather than a lack of demand for semiconductor tools overall. That presents a contrarian point: if order books for Veeco and Axcelis become more visible or diversify across additional customers or process steps, their equity discounts could compress rapidly given the leverage in their business models.

A non-obvious insight is that niche suppliers can act as leading indicators for specific node ramps. Because they serve narrow process steps, order acceleration at these vendors can presage broader tool integration cycles—and thus can offer high informational value to institutional allocators monitoring AI-related capex. Therefore, a disciplined monitoring framework that tracks tooling lead times, customer win rates and announced fab timelines can convert apparent idiosyncratic risk into an actionable signal for portfolio positioning. For more thematic context on semiconductors and AI capex, see our research hub topic and related pieces on supply-chain dynamics at topic.

From a portfolio-construction perspective, Fazen Capital emphasizes that smaller equipment suppliers should sit within an active sleeve where position sizing, stop-loss discipline, and event-driven entry criteria are applied. The historical pattern of amplitude in returns for niche equipment vendors argues for careful liquidity and risk management rather than passive benchmark allocation.

Bottom Line

Selectivity matters: strong industry billings do not automatically translate into uniform equity performance, and Veeco and Axcelis illustrate the divergence between concentrated exposure and benchmark-like scale. Monitor order books, fab ramps and customer diversification closely to interpret potential re-ratings.

Disclaimer: This article is for informational purposes only and does not constitute investment advice.